acetylcysteine has been researched along with Myelodysplastic Syndromes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, R; Huang, L; Jiang, H; Li, L; Liu, Z | 1 |
| Amer, J; Fibach, E; Ghoti, H; Rachmilewitz, E; Winder, A | 1 |
| Cattaneo, C; Cortelezzi, A; Cristiani, S; Gornati, G; Ibatici, A; Maiolo, AT; Motta, M; Pomati, M; Sarina, B; Silvestris, I; Volpe, AD | 1 |
3 other study(ies) available for acetylcysteine and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Decitabine shows synergistic effects with arsenic trioxide against myelodysplastic syndrome cells via endoplasmic reticulum stress-related apoptosis.
Topics: Acetylcysteine; Antioxidants; Apoptosis; Arsenic Trioxide; Cell Line, Tumor; Cell Proliferation; Decitabine; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Myelodysplastic Syndromes; Reactive Oxygen Species | 2019 |
Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Antioxidants; Blood Platelets; Chelating Agents; Deferiprone; Deferoxamine; Erythrocytes; Female; Humans; Male; Myelodysplastic Syndromes; Neutrophils; Oxidative Stress; Pyridones | 2007 |
Efficacy of N-acetylcysteine and all-trans retinoic acid in restoring in vitro effective hemopoiesis in myelodysplastic syndromes.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Apoptosis; Bone Marrow Cells; Female; Hematopoiesis; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Tretinoin; Tumor Necrosis Factor-alpha | 2000 |